Wenliang Wang

7.6k total citations · 1 hit paper
102 papers, 2.5k citations indexed

About

Wenliang Wang is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Wenliang Wang has authored 102 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 23 papers in Biomedical Engineering and 13 papers in Biomaterials. Recurrent topics in Wenliang Wang's work include Nanoplatforms for cancer theranostics (11 papers), RNA Interference and Gene Delivery (10 papers) and Nanoparticle-Based Drug Delivery (10 papers). Wenliang Wang is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), RNA Interference and Gene Delivery (10 papers) and Nanoparticle-Based Drug Delivery (10 papers). Wenliang Wang collaborates with scholars based in China, United States and Canada. Wenliang Wang's co-authors include Gerard D. Wright, Xifei Yu, Andrew King, Brian K. Coombes, Sarah A. Reid‐Yu, Dustin T. King, Timothy R. Walsh, N.C.J. Strynadka, Gianfranco De Pascale and Sanrong Liu and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Wenliang Wang

95 papers receiving 2.5k citations

Hit Papers

Aspergillomarasmine A overcomes metallo-β-lactamase antib... 2014 2026 2018 2022 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
    2014 429 citations Wenliang Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenliang Wang China 28 788 535 434 399 320 102 2.5k
Yun‐Chung Leung Hong Kong 35 1.6k 2.0× 439 0.8× 281 0.6× 642 1.6× 731 2.3× 124 3.8k
Fei Sun China 32 1.5k 1.9× 496 0.9× 240 0.6× 435 1.1× 236 0.7× 102 3.0k
Pan He China 25 634 0.8× 524 1.0× 248 0.6× 323 0.8× 367 1.1× 88 1.9k
Maryam Hashemi Iran 33 1.4k 1.8× 679 1.3× 124 0.3× 307 0.8× 221 0.7× 132 3.2k
Mingzhen Zhang United States 35 1.8k 2.3× 468 0.9× 229 0.5× 316 0.8× 278 0.9× 84 3.3k
Ipsita Roy India 32 2.5k 3.1× 642 1.2× 168 0.4× 391 1.0× 235 0.7× 144 4.1k
Wing‐Fu Lai Hong Kong 37 1.1k 1.4× 987 1.8× 320 0.7× 917 2.3× 338 1.1× 133 3.7k
Jingxiu Bi China 32 1.2k 1.5× 903 1.7× 183 0.4× 543 1.4× 135 0.4× 146 3.2k
Zhiqing Liu China 33 1.7k 2.2× 371 0.7× 77 0.2× 184 0.5× 662 2.1× 172 3.5k
Xinxin Li China 35 1.6k 2.0× 883 1.7× 117 0.3× 392 1.0× 213 0.7× 205 3.8k

Countries citing papers authored by Wenliang Wang

Since Specialization
Citations

This map shows the geographic impact of Wenliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenliang Wang more than expected).

Fields of papers citing papers by Wenliang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenliang Wang. The network helps show where Wenliang Wang may publish in the future.

Co-authorship network of co-authors of Wenliang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenliang Wang. A scholar is included among the top collaborators of Wenliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenliang Wang. Wenliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Xiangfeng, Wenliang Wang, Quan Xie, et al.. (2025). Weaning performance prediction in lactating sows using machine learning, for precision nutrition and intelligent feeding. Animal nutrition. 21. 222–233.
2.
Gu, Chen, et al.. (2025). Organic mechanoluminescent nanoparticles for biomedical applications. Chemical Science. 16(28). 12702–12717.
3.
Wang, Wenliang, et al.. (2024). CRISPR‐Cas9 mediated genome editing of Kluyveromyces marxianus for iterative, multiplexed gene disruption and pathway integration. Biotechnology and Bioengineering. 121(10). 3269–3282. 3 indexed citations
4.
Li, Jinxuan, Md. Abul Kalam Azad, Wenliang Wang, et al.. (2024). Dynamic distribution of gut microbiota-metabolites during post-weaning longissimus dorsi muscle development in Ningxiang pigs. Microbiology Spectrum. 12(10). e0081324–e0081324. 2 indexed citations
5.
6.
Hsieh, Ju-Chun, Ilya Pyatnitskiy, Wenliang Wang, et al.. (2023). Design of an injectable, self-adhesive, and highly stable hydrogel electrode for sleep recording. Device. 2(2). 100182–100182. 24 indexed citations
7.
Wang, Wenliang, et al.. (2023). Ultrasound-Triggered In Situ Photon Emission for Noninvasive Optogenetics. Journal of the American Chemical Society. 145(2). 1097–1107. 57 indexed citations
8.
Wang, Wenliang, Ilya Pyatnitskiy, Xiangping Liu, et al.. (2023). Ultrasound-Induced Cascade Amplification in a Mechanoluminescent Nanotransducer for Enhanced Sono-Optogenetic Deep Brain Stimulation. ACS Nano. 17(24). 24936–24946. 20 indexed citations
9.
Wang, Wenliang, et al.. (2023). Reversible, Covalent DNA Condensation Approach Using Chemical Linkers for Enhanced Gene Delivery. Nano Letters. 23(20). 9310–9318. 1 indexed citations
10.
Wang, Beilei, Fengming Zou, Wenliang Wang, et al.. (2023). Structure-based discovery of IHMT-IDH1-053 as a potent irreversible IDH1 mutant selective inhibitor. European Journal of Medicinal Chemistry. 256. 115411–115411. 3 indexed citations
11.
Wu, Yun, Ziping Qi, Beilei Wang, et al.. (2022). Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes. Journal of Medicinal Chemistry. 65(17). 11818–11839. 9 indexed citations
12.
Wang, Wenliang, et al.. (2022). Ultrasound triggered organic mechanoluminescence materials. Advanced Drug Delivery Reviews. 186. 114343–114343. 42 indexed citations
13.
Wang, Wenliang, et al.. (2022). Overcoming barriers in non-viral gene delivery for neurological applications. Nanoscale. 14(10). 3698–3719. 40 indexed citations
14.
Zhou, Bin, Xiaofei Liang, Husheng Mei, et al.. (2021). Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas. Journal of Medicinal Chemistry. 64(20). 15170–15188. 18 indexed citations
15.
Wang, Wenliang, et al.. (2021). Functional Choline Phosphate Lipids for Enhanced Drug Delivery in Cancer Therapy. Chemistry of Materials. 33(2). 774–781. 39 indexed citations
16.
Lin, Lin, Wenliang Wang, Xinxin Yan, et al.. (2020). Aza-crown ether locked on polyethyleneimine: solving the contradiction between transfection efficiency and safety during in vivo gene delivery. Chemical Communications. 56(41). 5552–5555. 12 indexed citations
17.
Jia, Longgang, Yuqing Liu, Wenliang Wang, et al.. (2020). Molecular Mediation of Prion-like α-Synuclein Fibrillation from Toxic PFFs to Nontoxic Species. ACS Applied Bio Materials. 3(9). 6096–6102. 7 indexed citations
18.
19.
Wang, Wenliang, Wenliang Wang, Zongru Jiang, et al.. (2020). All-trans retinoic acid exerts selective anti-FLT3-ITD acute myeloid leukemia efficacy through downregulating Chk1 kinase. Cancer Letters. 473. 130–138. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yun‐Chung Leung Breakdown of academic impact, for papers by Fei Sun Breakdown of academic impact, for papers by Pan He Breakdown of academic impact, for papers by Maryam Hashemi Breakdown of academic impact, for papers by Mingzhen Zhang Breakdown of academic impact, for papers by Ipsita Roy Breakdown of academic impact, for papers by Wing‐Fu Lai Breakdown of academic impact, for papers by Jingxiu Bi Breakdown of academic impact, for papers by Zhiqing Liu Breakdown of academic impact, for papers by Xinxin Li
Rankless by CCL
2026